Extreme insulin resistance: Clinical management by external subcutaneous insulin infusion

Diabetes and Metabolism

Volumn 23, Issue 6, 1997, Pages 533-536

  Lalej Bennis, D ^a   Selam, J L ^a   Fluteau Nadler, S ^a   M'Bemba, J ^a   Reach, G ^a   Sorel, G ^b   Bardin, C ^a   Zirinis, P ^a   Chast, F ^a   Elgrably, F ^a   Slama, G ^a  

^a HÔTEL DIEU   (France)

^b Hotel Dieu Hospital ^*  (Martinique)

Author keywords

Insulin pumps; Ketoacidosis; Polymyositis; Type B insulin resistance

Indexed keywords

21 PH U400 INSULIN; ENDOPANCRINE U100 LYOPHILIZED INSULIN; HUMAN INSULIN; HUMULIN U500; INSULIN; UNCLASSIFIED DRUG; VANADYL SULFATE;

ADULT; ARTICLE; CASE REPORT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN INFUSION; INSULIN PUMP; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; SUBCUTANEOUS DRUG ADMINISTRATION; TECHNICAL AID;

ADULT; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 1; FEMALE; GLYCOSURIA; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN RESISTANCE; PLASMA EXCHANGE;

EID: 6844252927     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Flier JS. Syndromes of insulin resistance. In : Becker KL, ed. K.L. Becker (ed), ≪ Principles and practice of endocrinology and metabolism ≫. J.B. Lippincott Philadelphia, 1995, 1249-1259.
2. Apostol D, Renard E, Lauton D, Bringer I, Jaffiol C. Traitement d'un diabète insulino-résistant par infusion sous-cutanée d'un mélange d'insuline et d'aprotinine. Infusystème, 1993, 10, 15.
3. Schade DS, William CD. In search of the subcutaneous-insulin-resistance syndrome.New Engl J Med, 1986, 315, 147-153.
4. Robert JJ. Exploration des syndromes d'hyperinsulinisme par résistance à l'insuline. Ann Pediatr (Paris), 1990, 37, 143-149.
5. Grau U, Saudek CD. Stable insulin preparations for implantable insulin pumps. Laboratory and animal trials. Diabetes, 1987, 36, 1453-1459.
6. Selam JL, Haardt MJ, Berne C, Slama G. La place actuelle des pompes externes dans le traitement du diabète insulino-dépendant. Diabète et Métabolisme (Paris), 1995, 21, 378-382.
7. Schuman E, Brady A, Gross G, Hayes J. Vascular access options for outpatient cancer therapy. Am J Surg, 1980, 153, 487-489.
8. Selam JL, Micossi P, Dunn FL, Nathan DM, Implantable Insulin Pump Trial Study Group. Clinical trial of programmable implantable insulin pump for type 1 diabetes. Diabetes Care, 1992, 15, 877-885.
9. Mirouze J, Selam JL., Saeidi S, Bousquet-Rouaud R. Experience with external insulin pumps using the intraperitoneal route in 31 type I diabetic patients continuously followed for at least four years. Diab Nutr Metab, 1990, 5, 185-189.
10. Hanaire-Broutin H, Broussolle C, Jeandidier N, et al. The EVADIAC Group Study. Feasability of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. Diabetes Care, 1995, 18, 388-391.